Barrett L, Mellor R, Ritter A, McLauchlan L, Kearnes M. Navigating the grey: experiences of incremental cannabis reform in Australia. Drug Alcohol Rev. 2022 Nov;41(7):1621-9. doi: 10.1111/dar.13518
Mellor R, Lancaster K, Ritter A. Examining untreated and treated alcohol problem resolution in an Australian online survey sample. Drug Alcohol Rev. 2021 Sep;40(6):1037-46. doi: 10.1111/dar.13257
Krieger T, Pearson I, Bell J, Doherty J, Robbins P. Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment. Diagn Pathol. 2020 Jan 30;15(1):6. doi: 10.1186/s13000-020-0927-9
Knoll S, Jochum D, Talbird S. Comparative cost benefit analysis of two new Pneumococcal Conjugate Vaccines (PHiD-CV and PCV-13). Klin Padiatr. 2010 Jun 1;222(Suppl 1):S51-2.